Results for tag: "Factor Viia Inhibitor"

The Factor Viia Inhibitor market is a segment of the Hematological Drugs market. Factor Viia Inhibitors are drugs used to treat a variety of hematological conditions, including hemophilia, thrombosis, and thrombocytopenia. These drugs work by inhibiting the activity of Factor Viia, a protein involved in the clotting process. Factor Viia Inhibitors are typically administered intravenously or subcutaneously, and can be used in combination with other drugs to treat more severe conditions. The Factor Viia Inhibitor market is highly competitive, with a number of companies offering products for the treatment of hematological conditions. Some of the major players in the market include Bayer, Pfizer, Novo Nordisk, and CSL Behring. Show Less Read more